For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Frequency Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 14

% Expired Patents = 28.6

Trademarks = 4

Forward Citations = 29

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Christopher Loose (14 out of 14 patents)

Will Mclean (14 out of 14 patents)

Megan Harrison (8 out of 8 patents)

4. Michael R Jirousek (6 out of 37 patents)

5. Melissa Hill-Drzewi (5 out of 5 patents)

6. Bradley Tait (2 out of 19 patents)

7. Rajesh Manchanda (2 out of 2 patents)

14 patents: Sort by Forward Citations

1. 11617745 - Compositions and methods for generating hair cells by downregulating FOXO (2023-04-04),

2. 11260130 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV (2022-03-01),

3. 11162071 - Compositions and methods for generating hair cells by upregulating JAG-1 (2021-11-02),

4. 11160868 - Thermoreversible compositions for administration of therapeutic agents (2021-11-02),

5. 11066419 - 1H-pyrrole-2,5-dione compounds and methods of using same (2021-07-20),

6. 11033546 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: I (2021-06-15),

7. 10383881 - 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same (2019-08-20),

8. 10220041 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds (2019-03-05),

9. 10213511 - Thermoreversible compositions for administration of therapeutic agents (2019-02-26),

10. 10201540 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I (2019-02-12),

11. 10016507 - Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III (2018-07-10),

12. 9968615 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 3-(pyridin-2-yl)-1H-indol-2-ol based compounds (2018-05-15),

13. 9913848 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using 1,2,3,4-tetrahydro-[1,4]diazepino[6,7, 1-hi]indolyl based compounds (2018-03-13),

14. 9913835 - Methods for controlled proliferation of stem cells / generating inner ear hair cells using N-(alkylcarbamoyl)-1H-pyrazol-4-yl)-nicotinamide based compounds (2018-03-13),

Company Overview

Frequency Therapeutics, Inc. is a biotechnology company based in Lexington, MA, focused on developing innovative therapies aimed at restoring lost function in hearing and other sensory disorders. The company specializes in harnessing the body's own regenerative capabilities through its proprietary drug development platform, which targets specific pathways to promote the regeneration of sensory cells. Frequency Therapeutics is committed to advancing its research to improve the quality of life for individuals affected by hearing loss and related conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#49 in Lexington, MA

#1,364 in Massachusetts

#22,344 in US

#42,312 in the World

Lexington, MA, United States of America

Frequency Therapeutics, Inc.

Forward Citations = 29

7 inventors:

Christopher Loose (14 out of 14 patents)

Will Mclean (14 out of 14 patents)

Megan Harrison (8 out of 8 patents)

4. Michael R Jirousek (6 out of 37 patents)

5. Melissa Hill-Drzewi (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Frequency Therapeutics, Inc.. Retrieved from https://idiyas.com/company/frequency-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…